JP2004531242A5 - - Google Patents

Download PDF

Info

Publication number
JP2004531242A5
JP2004531242A5 JP2002571881A JP2002571881A JP2004531242A5 JP 2004531242 A5 JP2004531242 A5 JP 2004531242A5 JP 2002571881 A JP2002571881 A JP 2002571881A JP 2002571881 A JP2002571881 A JP 2002571881A JP 2004531242 A5 JP2004531242 A5 JP 2004531242A5
Authority
JP
Japan
Prior art keywords
polypeptide
host cell
seq
amino acids
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002571881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004531242A (ja
JP3738008B2 (ja
Filing date
Publication date
Priority claimed from US09/804,615 external-priority patent/US20020055467A1/en
Application filed filed Critical
Publication of JP2004531242A publication Critical patent/JP2004531242A/ja
Publication of JP2004531242A5 publication Critical patent/JP2004531242A5/ja
Application granted granted Critical
Publication of JP3738008B2 publication Critical patent/JP3738008B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002571881A 2001-03-12 2002-03-12 神経栄養因子 Expired - Fee Related JP3738008B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/804,615 US20020055467A1 (en) 1998-07-06 2001-03-12 Novel neurotrophic factors
PCT/EP2002/002691 WO2002072826A2 (en) 2001-03-12 2002-03-12 Neurotrophic factors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005027109A Division JP2005198656A (ja) 2001-03-12 2005-02-02 神経栄養因子

Publications (3)

Publication Number Publication Date
JP2004531242A JP2004531242A (ja) 2004-10-14
JP2004531242A5 true JP2004531242A5 (enExample) 2005-06-23
JP3738008B2 JP3738008B2 (ja) 2006-01-25

Family

ID=25189406

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002571881A Expired - Fee Related JP3738008B2 (ja) 2001-03-12 2002-03-12 神経栄養因子
JP2005027109A Withdrawn JP2005198656A (ja) 2001-03-12 2005-02-02 神経栄養因子

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2005027109A Withdrawn JP2005198656A (ja) 2001-03-12 2005-02-02 神経栄養因子

Country Status (15)

Country Link
US (1) US20020055467A1 (enExample)
EP (2) EP1930439B1 (enExample)
JP (2) JP3738008B2 (enExample)
CN (1) CN1268744C (enExample)
AT (2) ATE378353T1 (enExample)
AU (1) AU2002240943B2 (enExample)
CA (1) CA2440767C (enExample)
CY (1) CY1111750T1 (enExample)
DE (1) DE60223511T2 (enExample)
DK (2) DK1373503T3 (enExample)
ES (2) ES2296899T3 (enExample)
NZ (1) NZ528790A (enExample)
PT (2) PT1373503E (enExample)
SI (2) SI1930439T1 (enExample)
WO (1) WO2002072826A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593133B1 (en) * 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
WO2000004050A2 (en) * 1998-07-14 2000-01-27 Janssen Pharmaceutica N.V. Neurotrophic growth factor
MXPA03005721A (es) * 2000-12-22 2004-04-21 Genentech Inc Uso novedoso de artemina, un miembro de la familia de ligandos gdnf.
US7442370B2 (en) * 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) * 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
CA2442159C (en) * 2001-03-28 2011-08-23 Biogen, Inc. Treatment using neublastin polypeptides
JP2005516949A (ja) * 2001-12-19 2005-06-09 リジュン・ワン Gdnfの骨格筋へのアデノ随伴ウイルス媒介性のデリバリー
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Jx日鉱日石エネルギー株式会社 潤滑油組成物
EP2301960A3 (en) * 2003-01-31 2011-08-03 Biogen Idec MA Inc. Polymer conjugates of mutated neublastin
NZ543365A (en) 2003-04-18 2009-02-28 Biogen Idec Inc Polymer-conjugated glycosylated neublastin
DE602004019524D1 (de) 2003-06-10 2009-04-02 Nsgene As Verbesserte sezernierung von neublastin
US7598059B2 (en) * 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
WO2005039643A2 (en) 2003-10-20 2005-05-06 Nsgene A/S In vivo gene therapy of parkinson's disease
DE602005022082D1 (de) * 2004-08-19 2010-08-12 Biogen Idec Inc Rückfaltung von proteinen der transforming-growth-factor-beta-familie
EP1786454B1 (en) * 2004-08-19 2010-07-21 Biogen Idec MA Inc. Neublastin variants
EP1937295A2 (en) * 2005-10-11 2008-07-02 NS Gene A/S Treatment of retinopathies using gfr 3 agonists
TWI501774B (zh) * 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
ES2450065T3 (es) * 2006-03-01 2014-03-21 Biogen Idec Ma Inc. Composiciones y métodos para la administración de proteínas de la familia de ligandos del GDNF
US8329655B2 (en) 2007-05-01 2012-12-11 Biogen Idec Ma Inc. Methods for increasing vascularization
US20110135648A1 (en) * 2007-08-08 2011-06-09 Biogen Idec Ma Inc. Anti-neublastin antibodies and uses thereof
US20100247437A1 (en) * 2007-10-01 2010-09-30 Vgx Pharmaceuticals, Llc Materials and methods for the delivery of biomolecules to cells of an organ
CA2813013C (en) * 2010-10-01 2019-10-22 Nsgene A/S Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
JP7235230B2 (ja) * 2018-05-17 2023-03-08 ヘリックスミス カンパニー, リミテッド 化学療法-誘発末梢神経病症と関連した神経病症性痛みの治療
CN117279657A (zh) 2021-05-18 2023-12-22 日本株式会社Ltt生物医药 用于治疗或预防伴随抗癌剂给药的障碍的医药组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184200B1 (en) * 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
KR100587556B1 (ko) 1996-05-08 2006-06-08 바이오겐 아이덱 엠에이 인코포레이티드 신경 및 신장 증식을 자극하기 위한 RET리간드(RetL)
US6593133B1 (en) * 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US6284540B1 (en) * 1998-09-29 2001-09-04 Washington University Artemin, a novel neurotrophic factor
JP2002531128A (ja) * 1998-12-09 2002-09-24 アムジエン・インコーポレーテツド 神経栄養因子grnf4
PT1185648E (pt) * 1999-06-22 2007-06-29 Genentech Inc Métodos e composições para a inibição do crescimento de células neoplásicas.

Similar Documents

Publication Publication Date Title
JP2004531242A5 (enExample)
JP2002513556A5 (enExample)
JP2002528060A5 (enExample)
JP2006149406A5 (enExample)
IL210455A (en) A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals
JP2006516189A5 (enExample)
JP2004536077A5 (enExample)
JP2008538183A5 (enExample)
JP2006187292A5 (enExample)
JP2003533167A5 (enExample)
JP2002510494A5 (enExample)
JP2001518304A5 (enExample)
JP2008529558A5 (enExample)
CA2529179A1 (en) Recombinant adeno-associated virus vector for treatment of alzheimer disease
JP2007502101A5 (enExample)
WO2004048402B1 (en) A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
JP2005502663A5 (enExample)
JP2004533846A5 (enExample)
JP2004532037A5 (enExample)
CA2423616A1 (en) Chemokine mutants in the treatment of multiple sclerosis
JP2004537284A5 (enExample)
JPH0195791A (ja) 新規なポリペプチド、その製法、そのためのベクター及びそれを含有する医薬
RU2004104335A (ru) Биологически активные пептиды
JP2009507474A5 (enExample)
JP2003334088A5 (enExample)